Skip to content
healthcare.dev

Duloxetine Delayed-Release

NDC 70518-0122, DULOXETINE HYDROCHLORIDE, capsule, delayed release pellets, from REMEDYREPACK INC..

Product NDC
70518-0122
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203088
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0122 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DULOXETINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
70518-0122-57051801220590 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (70518-0122-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b9f20917-9529-4c62-bafe-baae7f8d6c77

Use it

Look up 70518-0122 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0122 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-0122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.